Jakob Siedlecki
Papers
1
Total Citations
28
H-Index
1
About
Jakob Siedlecki is a leading ophthalmology researcher whose work focuses on the intersection of ocular oncology and glaucoma, particularly the long-term complications of radiation therapy for eye cancers. His most cited study, "Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy" (2017, 28 citations), provides critical comparative data on how different radiation modalities affect eye preservation. Siedlecki demonstrated that while both robotic radiosurgery and brachytherapy effectively treat uveal melanoma, they carry distinct risks for developing secondary glaucoma—a sight-threatening complication that can undermine the benefits of eye-sparing treatment. This work has helped clinicians weigh treatment options more carefully, balancing tumor control against the risk of radiation-induced ocular hypertension. Beyond this landmark paper, Siedlecki's research portfolio spans innovative surgical techniques and outcomes analysis in glaucoma management, making him a key voice in optimizing therapeutic strategies for patients facing both cancer and chronic eye disease. His findings continue to shape clinical guidelines and inspire further investigation into minimizing radiation-related ocular damage.
Research Focus
Key Achievements
Top Papers
- 1